Market Newsdesk

BOSTON, May 19, 2021 (GLOBE NEWSWIRE) — Strength Catalyst Partners (SCP), an executive coaching firm that helps clients overcome obstacles, seize opportunities and build confidence, today announced its Corporate Acclimation Coaching program. These on-demand, targeted coaching services help employers navigate business transformation, as in today’s corporate environment where companies are welcoming former and new employees back into the office. Designed for executives, managers and employees, the new coaching program focuses on identifying and utilizing ones’ strengths to adapt to, and succeed in, today’s constantly changing business landscape. 

“Today’s leaders carry an unprecedented, heavy burden. They are role models that have to balance their own struggles with making unpopular, but impactful decisions,” said Colleen Boselli, principal of Strength Catalyst Partners. “Our acclimation coaching services were developed at the request and suggestion of several clients who understand that a company cannot flourish when its primary assets – employees – are feeling unsettled. Our confidential, empathetic, productive coaching program is designed to be an essential tool for high-value employees at this critical time.”

SCP acclimation coaching offers transition-based programs that enable employees at every level of the organization to orient themselves to new, or changing, business environments. Packages are being designed for:

• Women-Empowering-Women – targeted support to reinforce equity and opportunity for female employees, led by female coaches
• Senior Decision/Policy Makers – customized executive coaching support for creating optimal back-to-normal-work plans for each unique organization
• In-The-Hot-Seat – personalized coaching services targeted at managers who are deftly and strategically executing the decisions made by leadership, while also navigating the concerns of high-performing team members

Strength Catalyst Partners’ highly skilled, experienced executive coaches have decades of “real world” corporate experience – and have survived and thrived as working parents too. SCP have coached hundreds of business professionals through job transitions, return-to-work from parental leave, and cultural relocation adjustments.

SCP’s robust client list includes professionals working in sectors such as high technology/search, sports/entertainment, hospitality/food service, internet/social media, consulting services, financial services, education, advertising, retail, biotech, consumer goods, academia, not-for-profit and more.

To learn more about SCP’s Corporate Acclimation Coaching programs, please visit: https://strengthcatalyst.com/corporate-acclimation-coaching/.

About Strength Catalyst Partners


Founded in 2007, Strength Catalyst Partners offer robust strength-based, executive coaching services, corporate webinars and workshops — all designed to support business growth. Clients come to SCP’s strength strategists for custom-designed programs that enable teamwork enhancement, CEO effectiveness, and leadership/managerial effectiveness. Motivated, high performers from startups, Fortune 500 organizations, non-profits, and academic institutions all turn to SCP to help realize their true potential. For more information on Strength Catalyst Partners, please visit: https://strengthcatalyst.com.

Media Contact: Erin Keefe
Email: [email protected]
Phone: (617) 512-9498

GREENWOOD VILLAGE, CO , May 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Pure Harvest Corporate Group, Inc. (OTCQB: PHCG), a publicly traded holding company focused on NextGen plant derived nutraceuticals and emerging industries, is pleased to announce continued increase in revenue via its most recent quarterly report. Highlights are as follows:

• Q1 2021 Revenues increased by 92.65% from Q4 2020 Revenue;
• Q1 2021 Revenue: $794,148 / Q4 2020 Revenue: $412,228;
• Q1 2021 Revenue: $794,148 /  2020 Year End Revenue: $735,690;
• Q1 2021 Revenue: $794,148 / Q1 2020 Revenue: $1,091

The significant increases are largely attributable to continued growth in sales at the Company’s Colorado marijuana operations located in Dumont, CO.  Additionally, the Company’s Test Kitchen subsidiary began generating revenue with the launch of their white label program and beta product release. To date, Test Kitchen has received several large wholesale purchase orders which exceeded sales milestones required to unlock additional equity funding under the terms of its quarter one preferred stock offering.  

“I’m extremely excited, but not surprised, to see our growth in multiple subsidiaries during the first quarter of 2021,” stated Matthew Gregarek, CEO, Pure Harvest Corporate Group. “We are building a robust organization capable of generating revenues in different business verticals and this quarter’s financials are beginning to show what this company is capable of.”

“To have a quarter like this one on top of a strong Q4 is truly rewarding and underscores the hard work of many team members,” continued Gregarek. “Not only did we dramatically outperform our fourth-quarter revenue figures, but our sales in Q1 2021 were greater than our sales during all of 2020. We are thrilled to see numbers like this and will continue to work diligently to build this business throughout the rest of 2021 and beyond.”

About Pure Harvest Corporate Group

Pure Harvest Corporate Group, Inc. (OTCQB: PHCG) is a publicly traded vertically integrated consumer product innovation business focused on NextGen plant derived nutraceuticals and emerging industries. The PHCG team is committed to formulating, manufacturing, and distributing high-quality cannabis and hemp derived cannabinoid consumer products in markets where it is legal to do so. The Company has developed numerous retail brands and product lines that are currently available for purchase in select markets. Pure Harvest intends to grow its marijuana, hemp derived cannabinoids, and research and development operations and expand globally as the laws regarding cannabis are reviewed and rewritten to repeal their prohibition.

Additionally, the Company may from time to time disclose material events via its website at http://www.PureHarvestGroup.com. 

About Test Kitchen

Test Kitchen, a subsidiary of Pure Harvest, is a laboratory for human potential – an experiment and experience for creating and sustaining the highest expression of life. Test Kitchen’s mission is to curate empirical physiology and cultivate predictable pharmacognosy to optimize mind-body-performance. To put it simply, Test Kitchen’s goal is to use its proprietary plant-based lifestyle formulas to help a person gain an unfair advantage over the person’s former self.

Forward-Looking Statements

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate. Future events and results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Company Contact:

Pure Harvest Corporate Group, Inc.
Sherry Andersen, Corporate Communications
[email protected]
Phone: 800-924-3716

PALO ALTO, Calif., May 19, 2021 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) today announced two executive leadership appointments that support the company’s long-term growth strategy and strategic priorities.
        
Greg Baxter has been named Chief Transformation Officer. In this role, Baxter will lead and cultivate the company’s digital capabilities to better serve customers while also significantly reducing operating costs. He joins HP from MetLife where he served as Chief Digital Officer. Baxter succeeds Marie Myers, who was named HP’s CFO earlier this year and had also been serving as Acting Chief Transformation Officer.

Didier Deltort has been named President of Personalization & 3D Printing. Reporting to Sarabjit Singh (Savi) Baveja, HP’s Chief Strategy & Incubation Officer, he will lead global end-to-end business management to drive commercial growth, create new businesses, and disrupt industries with HP 3D Printing technology and intellectual property. Deltort joins the company from Zimmer Biomet where he served as President of the Europe, Middle East and Africa business.

“Greg and Didier are highly accomplished executives who have each delivered exceptional results throughout their careers,” said Enrique Lores, President and Chief Executive Officer at HP Inc. “We continue to transform the way we operate and create new growth businesses for the future. These appointments will accelerate progress against key strategic priorities and help to drive long-term sustainable growth and value creation.”

Biographies

Greg Baxter – Prior to HP, Baxter served as Chief Digital Officer at MetLife, where he was responsible for leading digital strategy and platforms, enterprise data and analytics, digital automation and innovation to transform the customer experience. Under his leadership, MetLife delivered industry-leading growth through redesigned and expanded digital channels, new product launches, streamlined business processes and customer journeys.

Prior to MetLife, he served as Global Head of Digital at Citi, where he led the company’s digital transformation across businesses and geographies, and Managing Partner at Booz & Company, where he held leadership roles across the firm’s financial services, public sector and digital practices. He began his career at IBM, where he focused on driving large-scale transformation programs. He earned his bachelor’s degree in IT from Monash University and his MBA from Melbourne University.

Didier Deltort – Prior to HP, Deltort was President of the Europe, Middle East and Africa business at Zimmer Biomet, one of the world’s leading musculoskeletal healthcare companies, where he led the marketing, sales and distribution of complex hardware, software, and digital products, services and solutions across a diverse set of markets.

Prior to Zimmer Biomet, Deltort was Senior Vice President and General Manager, Global Healthcare Solutions and Partnerships at Boston Scientific Corporation. Previously, he spent 14 years with GE Healthcare in leadership positions across Europe, the Middle East, and the United States, including SVP of Global Monitoring Solutions and Managing Director of GE Healthcare Finland. He previously held leadership roles at Philips, Agilent, and Hewlett-Packard Company. He earned his master’s degree in biomedical engineering from University de Technologie de Compiègne, France.

About HP Inc.

HP Inc. creates technology that makes life better for everyone, everywhere. Through our product and service portfolio of personal systems, printers and 3D printing solutions, we engineer experiences that amaze. More information about HP Inc. is available at hp.com.

©Copyright 2021 HP Development Company, L.P. The information contained herein is subject to change without notice. The only warranties for HP products and services are set forth in the express warranty statements accompanying such products and services. Nothing herein should be construed as constituting an additional warranty. HP shall not be liable for technical or editorial errors or omissions contained herein.

Media Contact

HP Media Relations
[email protected]

San Francisco, May 19, 2021 (GLOBE NEWSWIRE) — Wine.com, the nation’s leading online wine retailer, today announced the appointment of Dawn Willoughby to its board of directors. 

Willoughby brings over 25 years of experience leading consumer businesses. She most recently served as Executive Vice President and Chief Operating Officer of the Clorox Company where she oversaw Marketing, Sales, Product Supply, Research & Development and Information Technology, as well as international and growth portfolio businesses.

“Dawn has executive leadership experience in a great many areas that will be helpful to Wine.com as we scale to the next level,” said Rich Bergsund, Wine.com CEO. “She’s also an accomplished athlete and a genuinely good person – a great fit with the Wine.com team.”

 “I am excited to join the Wine.com team,” said Willoughby. “The business is undergoing tremendous growth and there is a lot of upside as Wine.com provides unmatched selection, guidance, and convenience for customers.”

Willoughby held numerous senior management roles at The Clorox Company from 2001 through 2019. Prior to joining Clorox, she spent nine years with Procter & Gamble. Willoughby currently serves on the boards of TE Connectivity and the J.M. Smucker Company. Willoughby holds a bachelor’s degree from the University of Minnesota and an MBA from UCLA’s Anderson School of Management.

About Wine.com

Wine.com offers selection, guidance and convenience not found in stores – helping customers discover the incredible world of wine with confidence. Live chat sommeliers provide friendly advice and customers receive unlimited shipping all year by joining StewardShip. Wine.com was recently named Wine Enthusiast’s Retailer of the Year. For more information, visit the company’s website at www.wine.com or download its app in the Apple Store or Google Play.

Forward-looking statements

This press release contains forward-looking statements that relate to anticipated financial performance, management’s plans and objectives for future operations, business prospects, and other matters. Any forward-looking statement made in this press release speaks only as of the date on which it is made. Wine.com undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Actual events or results may differ materially from those described herein due to a number of risks and uncertainties. Wine.com cautions that these statements are subject to risks and uncertainties, many of which are outside of Wine.com’s control and could cause future events or results to be materially different from those stated or implied in this press release, or to not occur at all.  Given these uncertainties, you should not place undue reliance on these forward-looking statements.

KANSAS CITY, Mo., May 19, 2021 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share. The cash dividend will be payable on July 13, 2021, to shareholders of record as of the close of business on June 28, 2021.

Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be based on the company’s financial position, results of operations, cash flows, capital requirements, applicable law and any other factors the Board may deem relevant.

About Cerner

Cerner Corporation’s health technologies connect people and information systems in thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog or connect on Facebook, Instagram, LinkedIn, Twitter or The Cerner Podcast. Nasdaq: CERN. Health care is too important to stay the same.

All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner’s management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner’s performance, and actual results, financial condition or business could differ materially from those expressed in such forward- looking statements. The words “intends,” “future,” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. For example, our forward-looking statements include statements regarding future dividends. Factors that could cause or contribute to such differences include, but are not limited to the extent to which the COVID-19 pandemic and measures taken in response thereto could adversely affect our financial condition, future bookings and results of operations; the possibility of interruption at our data centers or client support facilities, or those of third parties with whom we have contracted (such as public cloud providers), that could expose us to significant costs and reputational harm; the possibility of increased expenses, exposure to legal claims and regulatory actions and reputational harm associated with a cyberattack or other breach in our IT security or the IT security of third parties on which we rely; potential claims for system errors and warranties or significant costs and reputational harm related to product and service-related liabilities; material adverse resolution of legal proceedings or other claims or reputational harm stemming from negative publicity related to such claims or legal proceedings; risks associated with our global operations, including without limitation greater difficulty in collecting accounts receivable; significant competition and our ability to anticipate or respond quickly to market changes, changing technologies and evolving pricing and deployment methods and to bring competitive new solutions, devices, features and services to market in a timely fashion; risks inherent with business acquisitions, strategic investments, collaborations and the failure to achieve projected synergies, or divestitures; managing growth in the new markets in which we offer solutions, health care devices or services; long sales cycles for our solutions and services; risks related to our dependence on strategic relationships and third party suppliers, including any impact to such supplier’s business resulting from the COVID-19 pandemic; risks associated with the loss or recruitment and retention of key personnel or the failure to successfully develop and execute succession planning to assure transitions of key associates and their knowledge, relationships and expertise; inability to achieve expected operating efficiencies and sustain or improve operating expense reductions or business disruptions or adverse tax consequences associated with restructuring, realignment and costs reduction activities; changing political, economic and regulatory influences, which could impact the purchasing practices and operations of our clients and increase costs to deliver compliant solutions and services; non-compliance with laws, regulations or certain industry initiatives or failure to deliver solutions or services that enable our clients to comply with laws or regulations applicable to their businesses; risks inherent in contracting with government clients, including without limitation, complying with strict compliance and disclosure obligations, navigating complex procurement rules and processes, and defending against bid protests; volatility and disruption resulting from global economic or market conditions, including the impact from the COVID-19 pandemic; risks associated with our outstanding and future indebtedness, such as compliance with restrictive covenants, which may limit our flexibility to operate our business; risk that our capital allocation strategy will not be fully implemented or enhance long-term shareholder value; changes in tax laws, regulations or guidance that could adversely affect our tax position and/or challenges to our tax positions in the U.S. and non-U.S. countries; the potential for losses resulting from asset impairment charges; potential variations in our sales forecasts compared to actual sales; risks that our revenue growth may be lower than anticipated and/or that the mix of revenue shifts to low margin revenue; variations in our quarterly operating results; and risks associated with fluctuations in foreign currency exchange rates. Additional discussion of these and other risks, uncertainties and factors affecting Cerner’s business is contained in Cerner’s filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Except as required by law, Cerner undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in our business, results of operations or financial condition over time.

Investor Contact:

Allan Kells, (816) 201-2445, [email protected]

Media Contact:

Stephanie Greenwood, Media Relations, [email protected]

TORONTO, May 19, 2021 (GLOBE NEWSWIRE) — Dividend Select 15 Corp. (The “Company”) declares its monthly distribution of $0.06192 per Equity share. The distribution is payable June 10, 2021 to shareholders on record as of May 31, 2021.

Under the distribution policy announced in September 2014, the monthly dividend payable on the Equity shares is determined by applying a 10.00% annualized rate on the volume weighted average market price (VWAP) of the Equity shares over the last 3 trading days of the preceding month. As a result, Equity shareholders of record on May 31, 2021 will receive a dividend of $0.06192 per share based on the VWAP of $7.43 payable on June 10, 2021. The yield will remain stable at 10.00% (based on the VWAP) under this distribution policy. 

Since inception, Equity shareholders have received a total of $8.08 per share inclusive of this distribution.

The Company invests in a portfolio of 15 Canadian companies selected from the following 20 company universe which are among the highest Canadian dividend yielding stocks. 

Investor Relations: 1-877-478-2372
Local: 416-304-4443
dividendselect15.com
[email protected]

CALGARY, Alberta, May 19, 2021 (GLOBE NEWSWIRE) — Global Helium Corp. (CSE: HECO) (the “Company” or “Global”) is pleased to announce that it has received approval to list its Common Shares for trading on the Canadian Securities Exchange (“CSE”), and that its shares will commence trading at the open of the market on Wednesday, May 19, 2021 under the trading symbol “HECO”.

The Company’s non-offering, long-form prospectus dated May 10, 2021 can be found at www.sedar.com. Additional information on the Company’s structure, financial history and the details of its land holdings and helium prospects in southern Saskatchewan can be found on the Company’s website at www.globalhelium.com.

The Company was formed as a result of approaches from multi-billion-dollar helium consumers who were unsatisfied with the existing suppliers and seeking more stable supply. The Company was subsequently funded by its founders with the sole purposes of (i) understanding the technical intricacies and constraints within the helium industry and market, (ii) identifying opportunities, (iii) capturing and operationally advancing those opportunities and (iv) producing helium to meet the needs of consumers.

The Global Helium team is a production-focused group of experienced technical professionals, who have become the go-to helium experts in Canada, given the depth of their first-mover helium activities over the last several years.

Wes Siemens, President of Global stated, “In a shift from operating quietly behind the scenes, we are delighted to become more recognized and begin trading on the CSE, a prominent public exchange for innovators and entrepreneurs. Our Company has a 100% working interest in approximately 85,000 ha (210,000 acres) at Vermillion Hills in the helium fairway in Saskatchewan, where helium production is subject to only a 4.25% royalty rate (95.75% Net Revenue Interest).” Siemens added, “We have identified a number of large structures, believed to contain helium, which we will confirm with additional geological, geophysical and engineering tools at our disposal. We are excited about the prospects on our lands and the growth opportunities that are available to us in an expanding helium market.”

ON BEHALF OF THE BOARD OF GLOBAL HELIUM CORPORATION

“Wes Siemens”

Wes Siemens, P.Eng.
President

For more information:

Global Helium Investor Relations
Tel: +1 877 816 8163
[email protected]

About Global Helium

Global Helium is an exploration stage company focused on the exploration, acquisition, development, and production of helium to meet the needs of increasing helium demand and shrinking helium supply in North America and around the world. The Company has a seasoned team of industry professionals and technical experts and has established connections with North American and international helium buyers. Together, the team has captured 100%-owned permits encompassing hundreds of thousands of acres prospective for helium in Saskatchewan’s well-established helium fairway. Find out more at: https://globalhelium.com/.

Forward-Looking Statements

No securities regulatory authority has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this news release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

TORONTO, May 19, 2021 (GLOBE NEWSWIRE) — North American Financial 15 Split Corp. (The “Company”) declares its regular monthly distribution of $0.11335 for each Class A share ($1.3602 annualized) and $0.05625 for each Preferred share ($0.675 annually). Distributions are payable June 10, 2021 to shareholders on record as at May 31, 2021.

Since inception Class A shareholders have received a total of $14.46 per share and Preferred shareholders have received a total of $8.88 per share inclusive of this distribution, for a combined total of $23.34.

The Company invests in a high quality portfolio consisting of 15 financial services companies made up of Canadian and U.S. issuers as follows: Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, Manulife Financial Corporation, Sun Life Financial, Great-West Lifeco, CI Financial Corp, Bank of America, Citigroup Inc., Goldman Sachs Group, JP Morgan Chase & Co. and Wells Fargo & Co.

Investor Relations: 1-877-478-2372
Local: 416-304-4443
www.financial15.com
[email protected]